Drugs Of Abuse (DOA) Testing Global Market Opportunities And Strategies To 2034

Published Jun 16, 2025

Length 325 Pages

SKU # BRC20104372

Description

Drugs Of Abuse (DOA) Testing Global Market Opportunities And Strategies To 2034 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global drugs of abuse (DOA) testing market as it emerges from the COVID-19 shut down.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market research findings.
Benchmark performance against key competitors.
Utilize the relationships between key data sets for superior strategizing.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Description:

Where is the largest and fastest-growing market for drugs of abuse (DOA) testing? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The drugs of abuse (DOA) testing market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market’s history and forecasts market growth by geography. It places the market within the context of the wider drugs of abuse (DOA) testing market; and compares it with other markets.

The report covers the following chapters

Introduction And Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by product and service, by sample type, by application and by end-user.
Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
Growth Analysis And Strategic Analysis- Framework Analysis on PESTEL, end use industries, market growth rate, global historic (2019-2024) and forecast (2024-2029, 2034F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods, forecast growth contributors and total addressable market (TAM).
Global Market Size And Growth - Global historic (2019-2024) and forecast (2024-2029, 2034F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods
Regional And Country Analysis- Historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison by region and country.
Market Segmentation- Contains the market values (2019-2024) (2024-2029, 2034F) and analysis for each segment by product and service, by sample type, by application and by end-user in the market. Historic (2019-2024) and forecast (2024-2029) and (2029-2034) market values and growth and market share comparison by region market.
Regional Market- Size And Growth Regional market size (2024), historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
Other Major And Innovative Companies- Details on the company profiles of other major and innovative companies in the market.
Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
Competitive Dashboard- Briefs on competitive dashboard of major players.
Key Mergers And Acquisitions- Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
Recent Developments- Information on recent developments in the market covered in the report.
Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
Conclusions And Recommendations- This section includes recommendations for drugs of abuse (DOA) testing providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

1) By Product And Service: Analyzers; Rapid Testing Devices; Consumables; Laboratory Services

2) By Sample Type: Urine; Hair; Oral Fluid; Breath; Other Sample Types

3) By Application: Pain Management; Criminal Justice; Workplace Screening

4) By End User: Hospitals; Diagnostics Laboratories; Forensic Laboratories; Other End Users

Companies Mentioned: Abbott Laboratories; Danaher Corporation (Beckman Coulter); Laboratory Corporation of America Holdings; Quest Diagnostics Inc.; Thermo Fisher Scientific Inc.

Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; UK; Italy; Spain; Russia

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time-series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; drugs of abuse (DOA) testing indicators comparison.

Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

1 Executive Summary: 1.1 Drugs Of Abuse (DOA) Testing – Market Attractiveness And Macro Economic Landscape
2 Table Of Contents
3 List Of Tables
4 List Of Figures
5 Report Structure
6 Market Characteristics: 6.1 General Market Definition; 6.2 Summary; 6.3 Drugs Of Abuse (DOA) Testing Market Definition And Segmentations; 6.4 Market Segmentation By Product And Service; 6.4.1 Analyzers; 6.4.2 Rapid Testing Devices; 6.4.3 Consumables; 6.4.4 Laboratory Services; 6.5 Market Segmentation By Sample Type; 6.5.1 Urine; 6.5.2 Hair; 6.5.3 Oral Fluid; 6.5.4 Breath; 6.5.5 Other Sample Types; 6.6 Market Segmentation By Application; 6.6.1 Pain Management; 6.6.2 Criminal Justice; 6.6.3 Workplace Screening; 6.7 Market Segmentation By End-User; 6.7.1 Hospitals; 6.7.2 Diagnostic Laboratories; 6.7.3 Forensic Laboratories; 6.7.4 Other End-Users
7 Major Market Trends: 7.1 Revolutionizing Drug Testing With Mass Spec Solution For Enhanced Accuracy And Efficiency; 7.2 Innovative Drugs Of Abuse Reagents Enhance Accuracy And Portability In Testing; 7.3 Expansion Of Urine Drugs Of Abuse Testing For Enhanced Accuracy And Rapid Detection
8 Global Drugs Of Abuse (DOA) Testing Growth Analysis And Strategic Analysis Framework: 8.1 Global Drugs Of Abuse (DOA) Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors); 8.1.1 Political; 8.1.2 Economic; 8.1.3 Social; 8.1.4 Technological; 8.1.5 Environmental; 8.1.6 Legal; 8.2 Analysis Of End-Users (B2B); 8.2.1 Hospitals; 8.2.2 Diagnostic Laboratories; 8.2.3 Forensic Laboratories; 8.2.4 Other End-Users; 8.3 Global Drugs Of Abuse (DOA) Testing Market Growth Rate Analysis; 8.4 Historic Market Growth, 2019 – 2024, Value ($ Million); 8.4.1 Market Drivers 2019 – 2024; 8.4.2 Market Restraints 2019 – 2024; 8.5 Forecast Market Growth, 2024 – 2029, 2034F Value ($ Million); 8.5.1 Market Drivers 2024 – 2029; 8.5.2 Market Restraints 2024 – 2029; 8.6 Forecast Growth Contributors/Factors; 8.6.1 Quantitative Growth Contributors; 8.6.2 Drivers; 8.6.3 Restraints; 8.7 Global Drugs Of Abuse (DOA) Testing Total Addressable Market (TAM)
9 Global Drugs Of Abuse (DOA) Testing Market Segmentation: 9.1 Global Drugs Of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 9.2 Global Drugs Of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 9.3 Global Drugs Of Abuse (DOA) Testing Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 9.4 Global Drugs Of Abuse (DOA) Testing Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 9.5 Global Drugs Of Abuse (DOA) Testing Market, Sub-Segmentation Of Analyzers, By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 9.6 Global Drugs Of Abuse (DOA) Testing Market, Sub-Segmentation Of Rapid Testing Devices, By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 9.7 Global Drugs Of Abuse (DOA) Testing Market, Sub-Segmentation Of Consumables, By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 9.8 Global Drugs Of Abuse (DOA) Testing Market, Sub-Segmentation Of Laboratory Services, By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
10 Drugs Of Abuse (DOA) Testing Market, Regional and Country Analysis: 10.1 Global Drugs Of Abuse (DOA) Testing Market, By Region, Historic and Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 10.2 Global Drugs Of Abuse (DOA) Testing Market, By Country, Historic and Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11 Asia-Pacific Market: 11.1 Summary; 11.2 Market Overview; 11.2.1 Region Information; 11.2.2 Market Information; 11.2.3 Background Information; 11.2.4 Government Initiatives; 11.2.5 Regulations; 11.2.6 Regulatory Bodies; 11.2.7 Major Associations; 11.2.8 Taxes Levied; 11.2.9 Corporate Tax Structure; 11.2.10 Investments; 11.2.11 Major Companies; 11.3 Asia-Pacific Drugs Of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 11.4 Asia-Pacific Drugs Of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 11.5 Asia-Pacific Drugs Of Abuse (DOA) Testing Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 11.6 Asia-Pacific Drugs Of Abuse (DOA) Testing Market: Country Analysis; 11.7 China Market; 11.8 Summary; 11.9 Market Overview; 11.9.1 Country Information; 11.9.2 Market Information; 11.9.3 Background Information; 11.9.4 Government Initiatives; 11.9.5 Regulations; 11.9.6 Regulatory Bodies; 11.9.7 Major Associations; 11.9.8 Taxes Levied; 11.9.9 Corporate Tax Structure; 11.9.10 Major Companies; 11.10 China Drugs Of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 11.11 China Drugs Of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 11.12 China Drugs Of Abuse (DOA) Testing Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 11.13 India Market; 11.14 India Drugs Of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 11.15 India Drugs Of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 11.16 India Drugs Of Abuse (DOA) Testing Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 11.17 Japan Market; 11.18 Summary; 11.19 Market Overview; 11.19.1 Country Information; 11.19.2 Market Information; 11.19.3 Background Information; 11.19.4 Government Initiatives; 11.19.5 Regulations; 11.19.6 Regulatory Bodies; 11.19.7 Major Associations; 11.19.8 Taxes Levied; 11.19.9 Corporate Tax Structure; 11.19.10 Investments; 11.19.11 Major Companies; 11.20 Japan Drugs Of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 11.21 Japan Drugs Of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 11.22 Japan Drugs Of Abuse (DOA) Testing Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 11.23 Australia Market; 11.24 Australia Drugs Of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 11.25 Australia Drugs Of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 11.26 Australia Drugs Of Abuse (DOA) Testing Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 11.27 Indonesia Market; 11.28 Indonesia Drugs Of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 11.29 Indonesia Drugs Of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 11.30 Indonesia Drugs Of Abuse (DOA) Testing Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 11.31 South Korea Market; 11.32 Summary; 11.33 Market Overview; 11.33.1 Country Information; 11.33.2 Market Information; 11.33.3 Background Information; 11.33.4 Government Initiatives; 11.33.5 Regulations; 11.33.6 Regulatory Bodies; 11.33.7 Major Associations; 11.33.8 Taxes Levied; 11.33.9 Corporate Tax Structure; 11.33.10 Major Companies; 11.34 South Korea Drugs Of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 11.35 South Korea Drugs Of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 11.36 South Korea Drugs Of Abuse (DOA) Testing Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12 Western Europe Market: 12.1 Summary; 12.2 Market Overview; 12.2.1 Region Information; 12.2.2 Market Information; 12.2.3 Background Information; 12.2.4 Government Initiatives; 12.2.5 Regulations; 12.2.6 Regulatory Bodies; 12.2.7 Major Associations; 12.2.8 Taxes Levied; 12.2.9 Corporate tax structure; 12.2.10 Investments; 12.2.11 Major Companies; 12.3 Western Europe Drugs Of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 12.4 Western Europe Drugs Of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 12.5 Western Europe Drugs Of Abuse (DOA) Testing Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 12.6 Western Europe Drugs Of Abuse (DOA) Testing Market: Country Analysis; 12.7 UK Market; 12.8 UK Drugs Of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 12.9 UK Drugs Of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 12.10 UK Drugs Of Abuse (DOA) Testing Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 12.11 Germany Market; 12.12 Germany Drugs Of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 12.13 Germany Drugs Of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 12.14 Germany Drugs Of Abuse (DOA) Testing Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 12.15 France Market; 12.16 France Drugs Of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 12.17 France Drugs Of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 12.18 France Drugs Of Abuse (DOA) Testing Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 12.19 Italy Market; 12.20 Italy Drugs Of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 12.21 Italy Drugs Of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 12.22 Italy Drugs Of Abuse (DOA) Testing Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 12.23 Spain Market; 12.24 Spain Drugs Of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 12.25 Spain Drugs Of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 12.26 Spain Drugs Of Abuse (DOA) Testing Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
13 Eastern Europe Market: 13.1 Summary; 13.2 Market Overview; 13.2.1 Region Information; 13.2.2 Market Information; 13.2.3 Background Information; 13.2.4 Government Initiatives; 13.2.5 Regulations; 13.2.6 Regulatory Bodies; 13.2.7 Major Associations; 13.2.8 Taxes Levied; 13.2.9 Corporate Tax Structure; 13.2.10 Major companies; 13.3 Eastern Europe Drugs Of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 13.4 Eastern Europe Drugs Of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 13.5 Eastern Europe Drugs Of Abuse (DOA) Testing Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 13.6 Eastern Europe Drugs Of Abuse (DOA) Testing Market: Country Analysis; 13.7 Russia Market; 13.8 Russia Drugs Of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 13.9 Russia Drugs Of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 13.10 Russia Drugs Of Abuse (DOA) Testing Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
14 North America Market: 14.1 Summary; 14.2 Market Overview; 14.2.1 Region Information; 14.2.2 Market Information; 14.2.3 Background Information; 14.2.4 Government Initiatives; 14.2.5 Regulations; 14.2.6 Regulatory Bodies; 14.2.7 Major Associations; 14.2.8 Taxes Levied; 14.2.9 Corporate Tax Structure; 14.2.10 Investments; 14.2.11 Major Companies; 14.3 North America Drugs Of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 14.4 North America Drugs Of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 14.5 North America Drugs Of Abuse (DOA) Testing Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 14.6 North America Drugs Of Abuse (DOA) Testing Market: Country Analysis; 14.7 USA Market; 14.8 Summary; 14.9 Market Overview; 14.9.1 Country Information; 14.9.2 Market Information; 14.9.3 Background Information; 14.9.4 Government Initiatives; 14.9.5 Regulations; 14.9.6 Regulatory Bodies; 14.9.7 Major Associations; 14.9.8 Taxes Levied; 14.9.9 Corporate Tax Structure; 14.9.10 Investments; 14.9.11 Major Companies; 14.10 USA Drugs Of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 14.11 USA Drugs Of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 14.12 USA Drugs Of Abuse (DOA) Testing Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 14.13 Canada Market; 14.14 Summary; 14.15 Market Overview; 14.15.1 Country Information; 14.15.2 Market Information; 14.15.3 Background Information; 14.15.4 Government Initiatives; 14.15.5 Regulations; 14.15.6 Regulatory Bodies; 14.15.7 Major Associations; 14.15.8 Taxes Levied; 14.15.9 Corporate Tax Structure; 14.15.10 Investments; 14.15.11 Major Companies; 14.16 Canada Drugs Of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 14.17 Canada Drugs Of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 14.18 Canada Drugs Of Abuse (DOA) Testing Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
15 South America Market: 15.1 Summary; 15.2 Market Overview; 15.2.1 Region Information; 15.2.2 Market Information; 15.2.3 Background Information; 15.2.4 Government Initiatives; 15.2.5 Regulations; 15.2.6 Regulatory Bodies; 15.2.7 Major Associations; 15.2.8 Taxes Levied; 15.2.9 Corporate Tax Structure; 15.2.10 Investments; 15.2.11 Major Companies; 15.3 South America Drugs Of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 15.4 South America Drugs Of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 15.5 South America Drugs Of Abuse (DOA) Testing Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 15.6 South America Drugs Of Abuse (DOA) Testing Market: Country Analysis; 15.7 Brazil Market; 15.8 Brazil Drugs Of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 15.9 Brazil Drugs Of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 15.10 Brazil Drugs Of Abuse (DOA) Testing Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
16 Middle East Market: 16.1 Summary; 16.2 Market Overview; 16.2.1 Region Information; 16.2.2 Market Information; 16.2.3 Background Information; 16.2.4 Government Initiatives; 16.2.5 Regulations; 16.2.6 Regulatory Bodies; 16.2.7 Major Associations; 16.2.8 Taxes Levied; 16.2.9 Corporate Tax Structure; 16.2.10 Investments; 16.2.11 Major Companies; 16.3 Middle East Drugs Of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 16.4 Middle East Drugs Of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 16.5 Middle East Drugs Of Abuse (DOA) Testing Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
17 Africa Market: 17.1 Summary; 17.2 Market Overview; 17.2.1 Region Information; 17.2.2 Market Information; 17.2.3 Background Information; 17.2.4 Government Initiatives; 17.2.5 Regulations; 17.2.6 Regulatory Bodies; 17.2.7 Major Associations; 17.2.8 Taxes Levied; 17.2.9 Corporate Tax Structure; 17.2.10 Major Companies; 17.3 Africa Drugs Of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 17.4 Africa Drugs Of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million); 17.5 Africa Drugs Of Abuse (DOA) Testing Market, Segmentation By Application, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
18 Competitive Landscape And Company Profiles: 18.1 Company Profiles; 18.2 Abbott Laboratories; 18.2.1 Company Overview; 18.2.2 Products And Services; 18.2.3 Financial Overview; 18.3 Danaher Corporation (Beckman Coulter); 18.3.1 Company Overview; 18.3.2 Products And Services; 18.3.3 Financial Overview; 18.4 Laboratory Corporation of America Holdings; 18.4.1 Company Overview; 18.4.2 Products And Services; 18.4.3 Financial Overview; 18.5 Quest Diagnostics Inc.; 18.5.1 Company Overview; 18.5.2 Products And Services; 18.5.3 Business Strategy; 18.5.4 Financial Overview; 18.6 Thermo Fisher Scientific Inc.; 18.6.1 Company Overview; 18.6.2 Products And Services; 18.6.3 Business Strategy; 18.6.4 Financial Overview
19 Other Major And Innovative Companies: 19.1 F. Hoffmann-La Roche Ltd.; 19.1.1 Company Overview; 19.1.2 Products And Services; 19.2 Drägerwerk AG & Co. KGaA; 19.2.1 Company Overview; 19.2.2 Products And Services; 19.3 Siemens Healthneers; 19.3.1 Company Overview; 19.3.2 Products And Services; 19.4 Bio-Rad Laboratories Inc.; 19.4.1 Company Overview; 19.4.2 Products And Services; 19.5 Agilent Technologies Inc.; 19.5.1 Company Overview; 19.5.2 Products And Services; 19.6 HireRight Holdings Corporation.; 19.6.1 Company Overview; 19.6.2 Products And Services; 19.7 Sonic Healthcare Limited; 19.7.1 Company Overview; 19.7.2 Products And Services; 19.8 LGC Limited; 19.8.1 Company Overview; 19.8.2 Products And Services; 19.9 DISA Global Solutions Inc.; 19.9.1 Company Overview; 19.9.2 Products And Services; 19.10 Randox Laboratories Ltd.; 19.10.1 Company Overview; 19.10.2 Products And Services; 19.11 Intoximeters Inc.; 19.11.1 Company Overview; 19.11.2 Products And Services; 19.12 First Advantage Corporation; 19.12.1 Company Overview; 19.12.2 Products And Services; 19.13 Cordant Health Solutions; 19.13.1 Company Overview; 19.13.2 Products And Services; 19.14 Precision Diagnostics LLC; 19.14.1 Company Overview; 19.14.2 Products And Services; 19.15 Omega Laboratories Inc.; 19.15.1 Company Overview; 19.15.2 Products And Services
20 Competitive Benchmarking
21 Competitive Dashboard
22 Key Mergers And Acquisitions: 22.1 Premier Biotech Inc., Acquired Desert Tox LLC; 22.2 Aegis Sciences Corporation Acquires Healthtrackrx’s Toxicology Business
23 Recent Developments in the Drugs of Abuse Testing Market: 23.1 Dual Blood Marker Test Launched For Enhanced Alcohol Monitoring
24 Opportunities And Strategies: 24.1 Global Drugs Of Abuse (DOA) Testing Market In 2029 – Countries Offering Most New Opportunities; 24.2 Global Drugs Of Abuse (DOA) Testing Market In 2029 – Segments Offering Most New Opportunities; 24.3 Global Drugs Of Abuse (DOA) Testing Market In 2029 – Growth Strategies; 24.3.1 Market Trend Based Strategies; 24.3.2 Competitor Strategies
25 Drugs Of Abuse (DOA) Testing Market, Conclusions And Recommendations: 25.1 Conclusions; 25.2 Recommendations; 25.2.1 Product; 25.2.2 Place; 25.2.3 Price; 25.2.4 Promotion; 25.2.5 People
26 Appendix: 26.1 Geographies Covered; 26.2 Market Data Sources; 26.3 Research Methodology; 26.4 Currencies; 26.5 The Business Research Company; 26.6 Copyright and Disclaimer

Search Inside Report

Pricing

Currency Rates

Single User Online Download $4,490
Site License Online Download $6,490
Global Site License Online Download $8,490

How Do Licenses Work?

Request A Sample

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.

Chat Now